Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Enzo Biochem (ENZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enzo Biochem 527 Madison Ave. New York NY 10022 USA

P: 212-583-0100

Description:

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.

Key Statistics

Overview:

Market Capitalization, $K 171,957
Shares Outstanding, K 47,241
Annual Sales, $ 104,710 K
Annual Net Income, $ -10,320 K
Last Quarter Sales, $ 19,330 K
Last Quarter Net Income, $ -8,410 K
60-Month Beta 1.40
% of Insider Shareholders 9.40%
% of Institutional Shareholders 67.11%
Float, K 42,800
% Float 90.60%

Growth:

1-Year Return -46.31%
3-Year Return -41.29%
5-Year Return -3.96%
5-Year Revenue Growth 11.74%
5-Year Earnings Growth 47.83%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 06/10/19
Earnings Per Share ttm -0.49
EPS Growth vs. Prev Qtr -38.46%
EPS Growth vs. Prev Year -350.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Most Recent Dividend 0.063 on 06/29/95
Dividend Payout Ratio 0.00

ENZ Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 0.00
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -29.83
Return-on-Assets (Before Tax) -23.74
Profit Margin % -9.86
Net Margin % -14.43
Debt/Equity 0.07
Price/Sales 1.66
Price/Cash Flow N/A
Price/Book 2.57
Book Value/Share 1.43
Interest Coverage N/A
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar